Mean platelet volume and red blood cell distribution width in prognosis of chronic hepatitis B.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

3 citing papers in PubMed.

1. Soluble MICB protein levels and platelet counts during hepatitis B virus infection and response to hepatocellular carcinoma treatment.BMC infectious diseases · 2015
   Article
2. Can mean platelet volume be a novel predictive marker in patients with pelvic inflammatory disease?Wiener klinische Wochenschrift · 2014
   Article
3. Mean platelet volume: a novel predictive marker for mortality in patients with acute mesenteric ischemia?World journal of emergency surgery : WJES · 2014
   Article

Corrections and comments

• Comment on
  A new model using platelet indices to predict liver fibrosis in patients with chronic hepatitis B infection.2013

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as